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Objectives: Diet-induced metabolic dysfunction such as type 2 diabetes mellitus
increases the risk of implant failure in both dental and orthopaedic settings. We hypo-
thesised that a diet high in fat and fructose would adversely affect peri-implant bone
structure and function including osseointegration.
Materials and methods: Thirty female Sprague-Dawley rats were divided into three
groups (n = 10), control group (normal chow) and two intervention groups on a high-
fat (60%), high-fructose (20%; HFHF) diet. Titanium implants were placed in the prox-
imal tibial metaphysis in all groups either before commencing the diet (dHFHF group)
or 6 weeks after commencing the diet (HFHF group) and observed for an 8-week
healing period. Fasting blood glucose levels (fBGLs) were measured weekly. Structural
and functional features of the peri-implant bone, including bone-to-implant contact
(BIC), were analysed post euthanasia using microcomputed tomography, pull-out
tests, and dynamic histomorphometry.
Results: The fBGLs were unchanged across all groups. Peri-implant trabecular bone
volume was reduced in the HFHF group compared with controls (p = .02). Percentage
BIC was reduced in both HFHF group (25.42 ± 3.61) and dHFHF group (28.56 ± 4.07)
compared with the control group (43.26 ± 3.58, p < .05) and reflected the lower pull-
out loads required in those groups. Osteoblast activity was reduced in both interven-
tion groups compared with the control group (p < .05).
Conclusion: The HFHF diet compromised osseointegration regardless of whether the
implant was placed before or after the onset of the diet and, despite the absence of
elevated fBGLs, confirming that changes in bone cell function affected both the initia-
tion and maintenance of osseointegration independent of blood glucose levels.
K E YWORD S
dental implant(s), histomorphometry, microcomputed tomography, osseointegration
Received: 17 June 2019 Revised: 2 September 2019 Accepted: 10 September 2019
DOI: 10.1002/cre2.255
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided
the original work is properly cited.
©2019 The Authors. Clinical and Experimental Dental Research published by John Wiley & Sons Ltd.
Clin Exp Dent Res. 2020;6:107–116. wileyonlinelibrary.com/journal/cre2 107
1 | INTRODUCTION
Titanium implants are an established treatment option for both dental
and orthopaedic rehabilitation, particularly in an ageing population
where demand is rapidly increasing (Srinivasan, Meyer, Mombelli, &
Muller, 2017). Although 10-year survival rates of 94.6% for dental
implants (Moraschini, Poubel, Ferreira, & Barboza Edos, 2015), 95.6%
for total hip replacements and 96.1% for total knee replacements have
been reported (Bayliss et al., 2017), failures do occur. Metabolic dys-
function such as type 2 diabetes mellitus (T2DM) has been shown to
be associated with reduced dental implant survival rates (Naujokat,
Kunzendorf, & Wiltfang, 2016) and an increased risk for revision of
total hip replacements (Pedersen, Mehnert, Johnsen, & Sorensen,
2010).
Normal bone remodelling processes are required for both initiation
and long-term maintenance of the bone-to-implant interface
(Terheyden, Lang, Bierbaum, & Stadlinger, 2012). Recent evidence
suggests that osseointegration is in fact a result of an immunologically
driven foreign body reaction mounted by the body in response to the
implant surface and that long-term maintenance of this interface
depends on equilibrium of this local inflammatory response, which
attenuates over time (Albrektsson, Chrcanovic, Jacobsson, &
Wennerberg, 2017; T. Albrektsson, Jemt, Molne, Tengvall, &
Wennerberg, 2019). There is now growing evidence that patient-
related risk factors may impact on the maintenance of this interface
(Maradit Kremers, Lewallen, van Wijnen, & Lewallen, 2016).
Diet, for example, can affect bone remodelling and, as such, the
potential success of implants. Diets high in saturated fats have been
shown to reduce trabecular bone microarchitecture in rodents
(Lac, Cavalie, Ebal, & Michaux, 2008; Li et al., 2017; Macri et al., 2012;
Yarrow et al., 2016), increase osteoclast activity, and expand bone
marrow fat (Li et al., 2017; Yarrow et al., 2016). Diets high in fructose,
which is metabolised in the liver into triglycerides and is associated
with insulin resistance (Elliott, Keim, Stern, Teff, & Havel, 2002), have
been shown to reduce the ex vivo osteogenic potential and increase
the ex vivo adipogenic potential of marrow stromal cells (Felice,
Gangoiti, Molinuevo, McCarthy, & Cortizo, 2014). A combination of
high fat and high fructose has been shown to result in uncoupling of
bone formation and resorption leading to reduced trabecular bone vol-
umes (Wong, Chin, Suhaimi, Ahmad, & Ima-Nirwana, 2018). Finally, a
diet high in fat has been shown to adversely affect the initiation of
osseointegration in both mini pigs and mice, respectively, by reducing
the bone-to-implant contact and biomechanical properties of the
interface (Coelho et al., 2018; Keuroghlian et al., 2015). The link
between diet and bone metabolism may be provided by the fact that
osteoblasts and adipocytes arise from a common mesenchymal stem
cell within the bone marrow and that lineage selection can be affected
by both local and systemic changes (Gregoire, Smas, & Sul, 1998).
Importantly, diet-associated negative effects on trabecular bone
microarchitecture may be sex-specific as the changes have been
shown to be greater in male mice compared with female mice
(Gautam et al., 2014). There are, however, no studies in female rodent
models relating to diet-induced changes in peri-implant bone
microarchitecture and osseointegration. Importantly, there are no
studies on the effect of diet on the maintenance of osseointegration.
Changes in bone microarchitecture may be reflected in changes in
function. Functional changes can be assessed by dynamic his-
tomorphometry, which enables the quantitative assessment of bone
formation over time and has been shown to be reduced in animals on
a high-fat diet (Tencerova et al., 2018). No studies have investigated
diet-induced changes to osteoblast cell function in peri-implant bone.
Preclinical animal models enable analysis of modifiable factors that
might affect osseointegration. As such, the aims of this study were to
test the hypothesis that a diet high in fat and fructose in female rats
adversely affects peri-implant bone microarchitecture,
osseointegration of a tibial titanium implant, and peri-implant osteo-
blast cell function.
2 | METHODS
2.1 | Experimental design
Twenty female Sprague Dawley rats (aged 8 weeks) obtained from the
Animal Resources Centre (Perth) were randomly divided into two
groups (n = 10): control group (Control, AIN93G Rodent Diet) and a
high-fat, high-fructose diet group (HFHF, SF02-006 60% fat modifica-
tion of AIN93G and 20% v/w fructose-enriched water). Animals were
maintained in individually ventilated cages, two rats per cage in a con-
trolled temperature, humidity, and light environment with alternating
12/12-hr light/dark cycles. Water and food were available ad libitum
except when the animals were fasted for 6 hr prior to blood collec-
tions. Animals were acclimatised for a 2-week period prior to the com-
mencement of experimental procedures and monitored daily for
the duration of the observation period. A sample size of five
animals per group was determined in a power calculation based on
bone-to-implant contact data presented in a T2DM rodent model
(Wang et al., 2011), and this sample size was used for dynamic his-
tomorphometry and pull-out tests; however, all analyses of peri-
implant bone microarchitecture were performed on a sample size of
10 animals per group. The study protocol was approved by the Uni-
versity of Sydney Animal Ethics Committee, protocol Number:
2016/1009, and complies with the ARRIVE guidelines for reporting
animal research (Kilkenny, Browne, Cuthill, Emerson, & Altman, 2010).
Implants were placed in the control group at Week 1 at the age of
10 weeks, and allowed to heal for an 8-week period. The HFHF group
commenced the HFHF diet at Week 1 at the age of 10 weeks, and the
implants were placed at Week 6, when the animals were 16 weeks
old. They were maintained on the HFHF diet and allowed to heal for a
further 8-week period (Figure 1).
To complement and extend this work, an additional group was
included in order to determine whether placement of the implant in a
metabolically healthy animal, with subsequent introduction of the
HFHF diet 4 weeks post implant placement, would compromise
osseointegration—this group was called the deferred HFHF group
(dHFHF, n = 10), bringing the total number of animals used in the
study to 30. In this group, the implant was placed at Week 1, at the
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age of 10 weeks, and the HFHF diet was commenced at Week 4 when
the animals were 14 weeks old; they were then maintained for a fur-
ther 8-week period on the HFHF diet (Figure 1). The 3-week healing
period was chosen as initial bone remodelling has been shown to take
place within 2 weeks in a canine model (Berglundh, Abrahamsson,
Lang, & Lindhe, 2003).
For all groups, weekly fasting blood glucose levels (fBGLs) were
measured following a 6-hr fast using an ACCU Check Performa
glucometer (Roche Diagnostic) and blood from the tail vein. Calcein
(10 mg/kg, Sigma Aldrich) was provided intraperitoneally at Day 9 and
Day 2 prior to sacrifice. At 8 weeks post implant placement for the
control and HFHF groups and 8 weeks post commencement of the
diet for the dHFHF group, the animals were anaesthetised with iso-
flurane, exsanguinated via cardiac puncture, and euthanised via decap-
itation. The right tibia was removed for microcomputed tomographic
analysis, histomorphometry, and pull-out testing.
F IGURE 1 Timeline of the experiment design; both the control group and the HFHF group had implant healing times of 8 weeks, with the
implants in the HFHF group being placed 6 weeks after the HFHF diet was introduced. The dHFHF group had an initial implant healing time of
4 weeks, the HFHF diet was introduced at Week 4, and the animals were maintained for a further 8-week period. dHFHF, deferred HFHF; HFHF,
high fat, high fructose
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2.2 | Implant placement
Animals were anaesthetised using a combination of 75-mg/kg body
weight ketamine (Ketamav 100, MAVLAB) and 10-mg/kg body weight
xylazine (Ilium Xylzil-20, Ilium) administered intraperitoneally. The
implant was inserted as previously described (Maïmoun et al., 2010;
Figure 2). Soft tissue closure was achieved and sutured using 3-0
resorbable sutures (Vicryl®). Postoperatively, the anaesthetic was
reversed using Atipamazole (Ilium, Troy Laboratories), and, once the
rats are awake, further postoperative analgesia (0.05- to 0.1-mg/kg
Buprenorphine [Temgesic®]) was provided immediately, followed by
1-mg/kg of Meloxicam and Enrofloxacin 5 mg/kg (Baytril®50) for
4 and 5 days, respectively. One animal from each intervention group
was lost due to anaesthetic complications.
2.3 | Microcomputed tomography
Post sacrifice, the right tibia containing the implant was dissected out
from each rat, excised, and fixed overnight in 4% paraformaldehyde
and then transferred to 70% ethanol (ETOH). The specimens were
wrapped in Parafilm to maintain hydration and scanned using the
Bruker SkyScan. Each scan was performed with a 10-μm voxel resolu-
tion, 0.14 rotation step, a projection time of approximately 590 ms,
and 180 tomographic rotation. The source was set to 100 kVp at
100 μA, and an aluminium filter (0.5 mm) was used to minimise beam
hardening artefacts. Scans were reconstructed in Nrecon (version
1.6.9.18) with all reconstruction parameters kept constant. Scans were
then realigned using DataViewer (version 64 V1.5.2.4), and a volume
of interest (VOI) was extracted from around the implant in the sagittal
orientation. A 0.5-mm × 1-mm-long region of trabecular bone was
defined around the implant and analysed via CTan (version V1.16)
with thresholds set for both bone and metal in order to segment the
image. The 3D parameters relative bone volume (BV/TV), trabecular
number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation
(Tb.Sp) were analysed within the VOI. The percentage of implant sur-
face in direct contact with trabecular bone (bone to implant contact)
within the VOI was measured following the Bruker method note
(MN074) as a 2D measurement of the intersection surface.
2.4 | Pull-out tests
To conduct the pull-out tests, five of the tibiae from each group were
sectioned about 15 mm from the proximal end, partially embedded in
epoxy resin and secured in a dynamic mechanical testing system
(ADMET eXpert 5951, USA). A constant displacement rate of
1 mm/min was used to load the implant, with the load values recorded
for the duration of the test. The pull-out value was determined as the
maximum load required to remove the implant.
2.5 | Histomorphometry
The remaining five tibiae from each group were embedded in resin
and prepared as previously described (Potres, Deshpande, Kloeppel,
Voss, & Klineberg, 2016). Briefly, the sections containing the implant
were dehydrated in ascending alcohol concentrations followed by
incubation in 100% acetone and then a 1:1 mixture of acetone and
infiltration media prior to embedding in Technovit 8100 Glycol Meth-
acrylate at 4C. A low-speed, low-deformation saw (Struers Accutom-
50) with a diamond wafering blade (12.7-cm diameter, 0.4 mm thick—
E015D) was used to section the resin blocks such that the implant
was sectioned in half along the long axis. The sectioned block was
then polished under water lubrication using silicon carbide paper
(500, 800, 1,200, and 4,000 grits), and the polished surface of the
block was glued to a microscope slide using clear epoxy resin and
allowed to dry for 24 hr. The block with the glass slide attached was
then returned to the low-deformation saw, and a section of approxi-
mately 200 μm was obtained by sectioning the block 200 μm from the
surface of the slide. The block attached to the slide was then ground
further on the tegrapol-25 to obtain a section thickness of between
60 and 80 μm.
Histomorphometric analysis was performed on unstained,
undecalcified 80- to 100-μm thick sections at ×20 magnification in a
F IGURE 2 (a) Radiographic image of the implant positioned in the tibial metaphysis. (b) Photographic image of the implant positioned in the
proximal tibia prior to achieving soft tissue closure
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series of three boxes (1,000 μm × 1,000 μm) positioned in trabecular
bone on either side of the length of the implant beginning at the top
end of the implant using the OsteoMeasure system (OsteoMeasureTM,
Osteometrics Inc.; Parfitt et al., 1987; Figure 3). The dynamic parame-
ters of mineral appositional rate (MAR), the mineralising surface per
bone surface (MS/BS), and the bone formation rate (BFR/BS) were
measured. Measurements were made by one blinded and calibrated
examiner and 20% of specimens remeasured following a 2-week inter-
val with an intraclass correlation coefficient of.98.
2.6 | Statistical analysis
Gaussian distribution of data was assessed using the Shapiro-Wilk
test, whereas data that were not normally distributed were log trans-
formed. Differences between groups were analysed using a one-way
analysis of variance followed by Tukey post hoc multiple comparisons
analysis in Graphpad Prism 7.0 (University Licence, San Diego, CA,
USA). Repeated measures over time (only for fasting blood glucose)
were analysed using a general linear mixed model repeated measures
analysis followed by a post hoc multiple comparisons (Bonferroni) in
SPSS (IBM SPSS Statistics 24, USA). The significance level was set at
p < .05 for all analyses, and results are presented as Mean ± SEM or as
box plots (median with interquartile ranges). The magnitude of change
in the pull-out tests was assessed using Cohen's effect size (ES), which
was defined as small, 0.2; moderate. 0.5; and large, 0.8 or very large,
1.2 (Cohen, 1988).
3 | RESULTS
3.1 | Fasting blood glucose levels
To determine the effect of the HFHF diet on blood glucose levels,
fBGLs were measured weekly; however, the Week 1 data were
excluded due to a procedural error in blood collection for the con-
trol group in that week—the fBGL was measured after induction of
anaesthesia (the anaesthesia was for collection of plasma for data
not reported in this study), and this resulted in a transient hyper-
glycaemia. This error was not repeated in subsequent measure-
ments, and the fBGLs were measured prior to induction of
anaesthesia. At Week 2, there were no significant differences in
fBGLs between the control group (6.9 ± 0.48 mmol/L) and the
HFHF group (5.7 ± 0.08 mmol/L) or the dHFHF group (6.3 ±
0.12 mmol/L). Neither were there any differences at the final time
point between the control group (5.35 ± 0.17 mmol/L), the HFHF
group (5.5 ± 0.18 mmol/L), and the dHFHF group (5.9 ±
0.18 mmol/L). The dHFHF group was the only group to show sig-
nificant changes in fBGLs during the study period (Figure 4).
F IGURE 3 Representative micrographic photographs visualised under UV excitation through a Dapi filter, demonstrating the positioning of
the first box (field of view) for dynamic histomorphometric measurements in an unstained, undecalcified section (4× magnification) (a). Higher
magnification views of the peri-implant region in the (b) control, (c) HFHF, and (d) dHFHF groups (20× magnification). The black arrow heads
indicate areas of double labelling, and the white arrowheads indicate areas of single labelling. dHFHF, deferred HFHF; HFHF, high fat, high
fructose
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3.2 | Peri-implant bone microarchitecture
To evaluate diet-induced changes in bone microarchitecture, peri-
implant samples were analysed 8 weeks following implant placement
in the control and HFHF groups and 12 weeks following implant
placement in the dHFHF group. Both the BV/TV and Tb. N in the
peri-implant region were significantly higher in the control group com-
pared with the HFHF group but not the dHFHF group. Additionally,
the Tb. Sp for the control group was significantly lower than that of
the HFHF group but not the dHFHF group. Finally, the Tb. Th for the
control group was not significantly different to either the HFHF or the
dHFHF group (Table 1).
3.3 | Osseointegration
To investigate the effect of a diet high in fat and fructose on
osseointegration, the percentage of peri-implant bone in contact with
the implant was determined and found to be significantly reduced in
both the HFHF (25.42 ± 3.61%, p = .006) and dHFHF groups (28.56 ±
4.07%, p = .03) compared with the control group (43.26 ± 3.58%). The
reduction in bone-to-implant contact was more marked in the HFHF
group, which started the diet prior to implant placement (Figure 5).
The bone-to-implant contact in the dHFHF group was significantly
lower than the control group despite the implant being in place for a
longer period (12 weeks compared with 8 weeks as the implant in the
HFHF group was placed 4 weeks prior to the commencement of the
diet).
3.4 | Pull-out tests
A reduction in bone-to-implant contact would be expected to reduce
the biomechanical strength of the interface; to test this hypothesis,
the load required to remove the implant was measured and found to
be lower in both the HFHF (82.03 ± 20.71 N, p = .42) and dHFHF
(71.21 ± 14.80 N, p = .17) compared with the control group (108.64 ±
5.8 N; Figure 5a). Some implants were partially cut during mechanical
gripping and fractured upon loading prior to producing pull-out force
data. This reduced the sample size and thus the statistical power, mak-
ing accurate differences between groups difficult to identify. There-
fore, Cohen's ES was used in order to investigate the magnitude of
the difference between the group means to provide an indication of
the strength of the effect of diet on osseointegration. Samples sizes in
Figure 3 are as follows: control, n = 4; HFHF, n = 3; and dHFHF, n =
4. Cohen's ES function revealed a large ES (1.03) for the HFHF and a
very large ES (1.72) for the dHFHF compared with the control group.
Implants failing above 100 N in all groups showed significant bone
adhesion following pull-out as illustrated by the control sample in
Figure 6b, whereas those failing below 100 N in all groups showed
very poor adhesion of bone to the implant surface following pull-out
as demonstrated by the HFHF and dHFHF samples in Figure 6c,d.
3.5 | Dynamic histomorphometry
To determine the cellular mechanisms of reduced trabecular
bone parameters and reduced osseointegration, dynamic
histomorphometric parameters of bone turnover in the peri-implant
F IGURE 4 Fasting blood glucose levels
(mmol/L): Week 2–Week 8 for the control (n =
10), Week 2–Week 14 for the HFHF (n = 9), and
Week 2–Week 12 for the dHFHF (n = 9) groups.
Results are presented as mean ± SEM. *p < .05 and
**p < .01 for differences within groups over time;
#p < .05 and ##p < .01 for the HFHF compared
with the dHFHF group as evaluated by a general
linear mixed model repeated measures analysis
followed by a post hoc multiple comparisons
(Bonferroni test). dHFHF, deferred HFHF; HFHF,
high fat, high fructose
TABLE 1 Trabecular bone microarchitecture parameters in the
peri-implant bone
Parameters Control HFHF dHFHF
Relative bone volume
(BV/TV; %)
22.12 ± 8.00 11.96 ± 7.41* 14.97 ± 7.05
Trabecular thickness
(Tb.Th; mm)
0.09 ± 0.02 0.07 ± 0.02 0.08 ± 0.02
Trabecular separation
(Tb.Sp; mm)
0.165 ± 0.01 0.184 ± 0.01** 0.175 ± 0.01
Trabecular number
(Tb.N; 1/mm)
2.5 ± 0.54 1.52 ± 0.55* 1.85 ± 0.68
Note. Control (n = 10), HFHF (n = 9), and dHFHF (n = 9). Data are
expressed as Mean ± SD.
Abbreviations: dHFHF, deferred HFHF; HFHF, high fat, high fructose.
*p < .05 HFHF compared with the control group as evaluated by a
one-way analysis of variance with post hoc multiple comparisons (Tukey
test).; **p < .001 HFHF compared with the control group as evaluated by a
one-way analysis of variance with post hoc multiple comparisons (Tukey
test).
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region were analysed. The MAR and BFR/BS were both significantly
reduced in the dHFHF group (p = .02 and p = .01, respectively) com-
pared with the control group. The MAR was also significantly lower in
the HFHF group (p = .04) compared with the control group. The
MS/BS was not significantly different in either the HFHF or dHFHF
group compared with the control group (Table 2).
4 | DISCUSSION
In summary, we report that a diet high in fat and fructose did not sig-
nificantly alter fBGLs in female rats. However, this diet did result in
compromised peri-implant trabecular bone microarchitecture, com-
promised bone-to-implant contact, and was associated with a reduc-
tion in the biomechanical properties of the interface. Furthermore,
this diet was associated with reduced osteoblast function in the peri-
implant region.
The effect of a diet high in fat and sugar on fBGLs is not clear.
Although diets high in fructose or fat and fructose (HFHF) have been
reported to increase fBGLs in male rats at 3 and 8 weeks (Dupas et al.,
2017; Huang, Chiang, Yao, & Chiang, 2004; Wong et al., 2018), other
studies have reported that fBGLs in male rats were unaltered 8 weeks
following high-fructose feeding (Sanchez-Lozada et al., 2007) and
16 weeks following high-fat/high-sugar feeding (Gerbaix et al., 2012).
Similarly, we did not observe a significant change in fBGLs in female
rats on an HFHF diet. However, despite the absence of a significant
effect on fBGLs, we did observe changes in bone structure and func-
tion. This suggests that the changes in bone tissue may be indepen-
dent of changes to circulating blood glucose levels. Similarly, a recent
study in minipigs on a diet high in fat has reported compromised
bone-to-implant contact regardless of the presence of hyperglycaemia
(Coelho et al., 2018).
This is the first study to report diet-induced changes in peri-
implant trabecular bone microarchitecture. Previous studies in rodent
models have reported that diets high in fat compromise tibial and fem-
oral trabecular bone microarchitecture (Lac et al., 2008; Macri et al.,
2012; Yarrow et al., 2016). In this study, 8 weeks following implant
F IGURE 5 Osseointegration is compromised in the HFHF and the dHFHF groups (p = .006 and p = .03, respectively) 8 weeks following
implant placement for the control and HFHF groups and 12 weeks following implant placement for the dHFHF group. (a) Percent bone-to-implant
contact. Results are expressed as box-and-whisker plots with the median, minimum, and maximum values; control (n = 10), HFHF (n = 9), and
dHFHF (n = 9). *p < .05 and **p < .01 compared with the control group as evaluated by a one-way analysis of variance with post hoc multiple
comparisons (Tukey test). (b–d) Reconstructed microcomputed tomography images of (b) control, (c) HFHF, and (d) dHFHF. dHFHF, deferred
HFHF; HFHF, high fat, high fructose
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placement, compromised trabecular bone microarchitecture was noted
in the HFHF group compared with the control group. The 8-week
healing period corresponded to approximately 5 years in human terms
(Andreollo, Santos, Araújo, & Lopes, 2012). Trabecular bone micro-
architecture in the dHFHF group was not compromised following
8 weeks on the HFHF diet. Importantly, the implant in the dHFHF
group was placed 4 weeks prior to the commencement of the HFHF
diet, resulting in a total of 12 weeks of healing compared with 8 weeks
of healing in the HFHF group and the control group. This may have
resulted in improved peri-implant microarchitecture in the dHFHF
group.
This study is the first to report that bone-to-implant contact is
compromised even when the HFHF diet is commenced after initial
implant integration has occurred. Compromised bone-to-implant con-
tact was noted in both the HFHF and dHFHF groups despite the
increased healing time in the dHFHF group. A similar high-fat-diet-
induced reduction in bone-to-implant contact has been reported in
female minipigs and male mice (Coelho et al., 2018; Keuroghlian et al.,
2015). However, in both these studies, the high-fat diet was com-
menced prior to implant placement. Trabecular bone outcomes have
been reported to be worse in male compared with female rats
(Gautam et al., 2014), and this study supports this finding, reporting a
reduction of less than 20% in bone-to-implant contact compared with
over 20% in male mice (Keuroghlian et al., 2015). The data from the
pull-out tests suggest that the biomechanical properties of the inter-
face may be compromised in both the intervention groups, and the rel-
atively less bone tissue adhered to the extracted implant (Figure 6)
noted in these groups supports this finding.
Healing of the osteotomy occurs through a process of distance
osteogenesis and contact osteogenesis. In the former case, osteo-
blasts migrate from within the native bone to the surface of the osteo-
tomy and start forming new bone along the walls of the osteotomy. In
the latter case, osteoprogenitor cells colonise the implant surface, dif-
ferentiate to form osteoblasts, and form new bone along the surface
of the implant (Davies, 1998). It is possible that the mechanism for dis-
tance osteogenesis is less compromised by the HFHF diet as bone can
be formed by osteoblasts already present within the native bone
microenvironment and that the reduced bone-to-implant contact in
both intervention groups may reflect compromised osteoblast differ-
entiation and bone formation that is required for contact osteogenesis
to occur. Indeed, a high-fat diet has been shown to reduce the osteo-
genic potential of bone marrow (Felice et al., 2014).
F IGURE 6 The load required to break the bone-to-implant interface is higher in the control group compared with both intervention groups
although not statistically significant. (a) Load (N) required to remove the implant from bone. Results are expressed as box-and-whisker plots with
the median, minimum, and maximum values; *large effect size and **very large effect size compared with the control group. Control (n = 4), HFHF
(n = 3), and dHFHF (n = 4). Photographic images of the implant after removal from the tibia: the black arrowheads indicate bone tissue attached to
the implant surface—with an increased amount of bone attached to the control implant (b) as compared with implants from the HFHF group
(c) and dHFHF group (d). dHFHF, deferred HFHF; HFHF, high fat, high fructose
TABLE 2 Dynamic histomorphometric parameters in the peri-implant bone
Parameters Control HFHF dHFHF
Mineral appositional rate (μm/d) 16.76 ± 10.39 5.32 ± 3.15* 4.01 ± 3.00†
Bone formation rate/bone surface (μm3/μm2/d) 55.22 ± 27.73 29.02 ± 18.95 12.87 ± 8.49†
Mineralising surface/bone surface (%) 344.17 ± 103.66 565.55 ± 143.22 453.19 ± 283.32
Note. Control (n = 5), HFHF (n = 5), and dHFHF (n = 5). Data are expressed as Mean ± SD.
Abbreviations: dHFHF, deferred HFHF; HFHF, high fat, high fructose.
*p < .05 HFHF compared with the control group.; †p < .05 dHFHF compared with the control group as evaluated by a one-way analysis of variance with
post hoc multiple comparisons (Tukey test).
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This is the first study to report on diet-induced changes in peri-
implant trabecular bone osteoblast function. The MAR was reduced in
both intervention groups, reflecting the reduced rate of matrix pro-
duction by osteoblasts. A similar high-fat-diet-induced reduction in
tibial and vertebral MAR and BFR has been reported in male mice
(Tencerova et al., 2018). The BFR provides a measure of both the vol-
ume of matrix production (MAR) and the area of bone surface covered
by active osteoblasts (MS/BS) and was reduced in the dHFHF group.
These findings suggest that a diet high in fat and fructose compro-
mises osseointegration by adversely affecting peri-implant osteoblast
function. The high fat content of the diet could result in an increase in
plasma free fatty acids, which have been shown to stimulate the pro-
duction of proinflammatory cytokines by osteoblasts, in turn leading
to bone loss (Frommer et al., 2017).
A limitation of this study was that the effect of hyperglycaemia on
peri-implant bone could not be determined because fBGLs did not
increase over time. The key aims of this study were to assess the
effect of diet-induced metabolic dysfunction on both the initiation
and maintenance of osseointegration; this meant that the groups had
to be of different ages at the end of the study period. Differences in
ages were due to the need to test implant healing before and after the
commencement of the diet with a standardised implant healing time
of 8 weeks for each group. Ideally, the use of two control groups to
match each of the intervention groups would have been useful but
would have significantly increased the number of animals and was not
possible due to constraints imposed by the Animal Ethics Committee.
Although bone tissue function can be affected by age, in rodents, both
trabecular and cortical bone has been shown to be stable between the
ages of 12 and 24 weeks (Barbier et al., 1999). Lastly, the pull-out
tests resulted in damage to a number of implants, compromising the
samples and making the final sample size too small for meaningful sta-
tistical analyses.
5 | CONCLUSIONS
In conclusion, we have shown that an HFHF diet in female rats signifi-
cantly compromises implant osseointegration despite the absence of
metabolic changes to fBGLs and regardless of whether the implant is
placed either before or after the onset of the diet. Changes in bone
microarchitecture are supported by changes in cellular function over
time. These changes indicate an underlying alteration in the regulation
of osteoblast function and are an important step in understanding the
mechanism behind the influence of diet on osseointegration. Diets
high in fat and fructose could compromise the bone-to-implant inter-
face and contribute to the development of late implant failures in
patients with underlying systemic conditions such as T2DM. As such,
dietary interventions could be considered in high-risk patients requir-
ing implants and in those with previously placed implants.
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